Can I Take Wegovy While Breastfeeding? Navigating Weight Loss and Lactation

Introduction

The postpartum period is a unique and often demanding chapter in a woman's life, filled with the boundless joys of new motherhood alongside significant physical and emotional transformations. Many new mothers find themselves navigating the desire to reclaim their health and body image, often facing persistent challenges with weight management. This journey, while personal, frequently leads to questions about various weight loss solutions, especially when breastfeeding. The intersection of effective weight management and the safety of a nursing infant is a topic of immense importance, demanding careful consideration and evidence-based insights.

In this comprehensive guide, we will explore the intricate question: "Can I take Wegovy while breastfeeding?" Our purpose is to shed light on the current scientific understanding, discuss the nuances of medication safety during lactation, and provide a framework for making informed decisions. We will delve into what Wegovy (semaglutide) is, how it works, and what research tells us about its presence in breast milk and its potential effects on nursing infants. Furthermore, we'll differentiate between injectable and oral forms of semaglutide, examine the broader implications for maternal nutrition and milk supply, and touch upon considerations for its use during pregnancy.

We understand that every mother's journey is unique, and decisions about personal health, particularly when intertwined with infant well-being, require a deeply personalized approach. At TrimRx, our journey began with a shared vision to help individuals embrace healthier lifestyles by merging cutting-edge telehealth innovations with effective weight loss solutions. We believe that sustainable weight loss should be achieved through science, empathy, and a transparent approach. This post is designed to be a supportive and authoritative resource, providing clarity amidst conflicting information and empowering you to have well-informed conversations with your healthcare provider. We'll outline the key factors to consider, highlighting how a personalized, medically supervised program can support your health goals safely and effectively.

Understanding Wegovy and Semaglutide: A Modern Approach to Weight Management

Weight management has evolved significantly, moving beyond simple calorie counting to embrace a deeper understanding of metabolic science. Medications like semaglutide, the active ingredient in Wegovy, represent a pivotal advancement in this field, offering a scientifically backed approach to addressing the physiological underpinnings of weight gain.

What is Semaglutide?

Semaglutide belongs to a class of medications known as GLP-1 (Glucagon-Like Peptide-1) receptor agonists. These medications mimic the action of a natural hormone called GLP-1, which plays a crucial role in regulating appetite and metabolism. Semaglutide works by:

• Increasing insulin release: It stimulates the pancreas to release more insulin when blood sugar levels are high, helping to lower blood glucose.
• Slowing gastric emptying: It slows down how quickly food leaves the stomach, which helps you feel fuller for longer and reduces overall food intake.
• Reducing appetite and cravings: By acting on the brain's appetite centers, semaglutide helps to decrease hunger and reduce cravings, making it easier to adhere to a reduced-calorie diet.

This multifaceted mechanism not only aids in blood sugar control for individuals with type 2 diabetes but also leads to significant and sustainable weight loss for those struggling with obesity or overweight, when combined with diet and exercise.

Semaglutide is available under several brand names, each approved for specific indications:

• Wegovy®: An injectable form, Wegovy® is FDA-approved specifically for chronic weight management in adults and adolescents aged 12 and older with obesity, or overweight adults with at least one weight-related medical condition, alongside a reduced-calorie diet and increased physical activity. It is also approved to reduce the risk of major cardiovascular events in adults with known heart disease and either obesity or overweight.
• Ozempic®: Another injectable form, Ozempic® is FDA-approved for improving blood sugar control in adults with type 2 diabetes and to reduce the risk of major cardiovascular events in adults with type 2 diabetes and established cardiovascular disease. While not explicitly approved for weight loss, it often leads to significant weight reduction as a beneficial side effect.
• Rybelsus®: An oral tablet form, Rybelsus® is FDA-approved for type 2 diabetes.

At TrimRx, we are proud to offer access to various GLP-1 medications, including Compounded Semaglutide, Oral Semaglutide, Ozempic®, Compounded Tirzepatide, Oral Tirzepatide, Mounjaro®, Zepbound®, and Wegovy®. These options are available through our personalized programs, which begin with a free assessment quiz to determine your eligibility and ensure you receive a tailored treatment plan from a licensed healthcare provider.

The Role of GLP-1 Agonists in Sustainable Weight Loss

The integration of GLP-1 agonists into weight management strategies signifies a move towards more effective and sustainable outcomes. These medications address metabolic dysregulation that often makes weight loss challenging through diet and exercise alone. They don't replace healthy lifestyle changes but rather enhance their effectiveness, helping individuals achieve and maintain weight loss by targeting the underlying biological mechanisms that regulate hunger and satiety.

At TrimRx, we believe in this synergistic approach. Our platform is a user-friendly and supportive space where individuals receive personalized, medically supervised care—all designed to make sustainable weight loss attainable and tailored to the individual. We combine advanced medical science with modern technology to offer compassionate care that respects every individual’s unique journey. Our commitment is to provide clinically proven, personalized weight loss solutions dedicated to safe, effective weight loss and individualized care.

Breastfeeding and Medication: General Considerations

Navigating medication use while breastfeeding is a common concern for new mothers. The principle guiding such decisions is always to weigh the benefits of treatment for the mother against any potential risks to the breastfed infant.

The Nuances of Drug Transfer to Breast Milk

When a mother takes medication, a small amount of the drug can potentially pass into her breast milk. However, it's crucial to understand that not all medications transfer in significant amounts, and many common drugs are considered safe for breastfeeding mothers under medical guidance. A majority of medications, including everyday painkillers and allergy relief, are not explicitly licensed for breastfeeding. This does not automatically mean they are unsafe; rather, it highlights the need for a healthcare provider's expert judgment.

Several factors influence how much of a drug might transfer to breast milk and its potential impact on an infant:

• Drug Properties: The molecular size, fat solubility, and protein binding of a drug affect its ability to cross into breast milk.
• Maternal Dosage and Duration: Higher doses or prolonged use can increase exposure.
• Infant's Age and Health: Premature infants, newborns, or those with underlying health conditions may be more sensitive to even small amounts of medication. Older infants who consume less breast milk or are already on solids may have less exposure.
• Volume of Breast Milk Consumed: A newborn feeding frequently will have greater potential exposure than an older baby who nurses only occasionally.
• Oral Bioavailability in Infants: Many drugs are poorly absorbed orally by infants, meaning even if they pass into breast milk, they might not enter the infant's bloodstream in significant quantities.

Generally, less than 1% of most drugs are likely to pass through to an infant via breast milk, a concentration that is often not enough to cause significant concern. However, this is a generalization, and specific medications require individual assessment.

The Importance of Expert Guidance

Given the complexities involved, it is paramount to consult with a healthcare professional before taking any medication while breastfeeding. Your doctor, pharmacist, or a lactation consultant can provide personalized advice based on your specific situation, your baby's health, and the latest research. They consider your medical history, the necessity of the treatment, and alternative options if available.

At TrimRx, our empathetic and supportive approach extends to ensuring you receive expert guidance. Our programs include comprehensive service that involves doctor consultations, where healthcare providers assess your eligibility and help you navigate treatment decisions, including those related to breastfeeding. We believe in providing transparent service, ensuring you have all the information needed to make informed choices for your health and your family's well-being.

Can I Take Wegovy While Breastfeeding? What the Research Says

The question of whether one can take Wegovy (semaglutide) while breastfeeding is a critical one for many new mothers. Current research offers valuable, albeit still evolving, insights into the safety profile of semaglutide during lactation. It's important to distinguish between the injectable and oral forms of the medication, as their properties and available data differ.

Injectable Semaglutide (like Wegovy and Ozempic) and Breast Milk

For injectable forms of semaglutide, such as Wegovy® and Ozempic®, the available data is encouraging but still limited. Key findings from reputable sources provide a clearer picture:

• Undetectable Levels in Breast Milk: Studies cited by databases like LactMed (Drugs and Lactation Database) indicate that semaglutide was not detectable in the breast milk of mothers taking subcutaneous (injectable) semaglutide. For instance, research involving eight nursing mothers who received subcutaneous semaglutide (0.25 mg to 1 mg weekly) found no measurable semaglutide (<1.7 mcg/L) in their milk samples at various time points after a dose.
• Very Low Relative Infant Dose (RID): Based on these findings, even if semaglutide were present at the detection limit, the calculated Relative Infant Dose would average only about 1.12%. This is significantly below the commonly accepted safety threshold of 10% for most medications, suggesting minimal exposure for the infant.
• Observed Infant Outcomes: In the aforementioned study, the breastfed infants (aged 4 to 23 months, mixed-fed for 3 to 9 weeks while mothers took semaglutide) were reported to have normal growth and development by their mothers, with no adverse effects observed.
• Limitations of Current Research: While promising, it's crucial to acknowledge the limitations. The sample sizes in these studies are small, meaning the findings cannot be universally applied to all breastfeeding populations. Additionally, the studies primarily involved mothers with mature breast milk, so the applicability to mothers of newborns or those in the initial colostrum stages is not yet fully established. More extensive, long-term research is still needed to provide a definitive understanding.

Given these insights, injectable semaglutide may be considered during breastfeeding under strict medical supervision, especially if the benefits for the mother outweigh the theoretical risks. Our personalized weight loss programs, which offer access to Compounded Semaglutide, Ozempic®, Wegovy®, Compounded Tirzepatide, Mounjaro®, and Zepbound®, all require you to complete our free assessment quiz to determine your eligibility and receive a personalized treatment plan developed in consultation with a licensed healthcare provider.

Oral Semaglutide (Rybelsus) and Breastfeeding

In contrast to injectable forms, oral semaglutide (Rybelsus®) presents greater concerns regarding breastfeeding. The key difference lies in the formulation:

• Absorption Enhancer: Oral Rybelsus® contains an absorption enhancer called salcaprozate sodium. There is a theoretical concern that this additive could enter breast milk and potentially accumulate in infants. The safety profile of salcaprozate sodium in breastfed infants has not been extensively studied.
• Lack of Data: Currently, there is no published data on the use of the oral form of semaglutide during breastfeeding. Due to this lack of specific safety information and the theoretical risks posed by the absorption enhancer, product labels for Rybelsus® generally recommend against its use in breastfeeding women.

Therefore, most healthcare providers advise avoiding oral semaglutide while breastfeeding unless a thorough risk-benefit analysis by a qualified professional strongly suggests otherwise. If you're considering Oral Semaglutide or Oral Tirzepatide through our programs, remember that taking our free assessment quiz is the first step to discussing these options with a healthcare provider and determining the safest path forward.

Our Stance on Medication Safety

At TrimRx, our commitment to your health and safety is paramount. We understand the critical importance of ensuring that any weight loss solutions we offer are provided with the highest standards of care.

• FDA-Registered and Inspected Pharmacies: We exclusively partner with FDA-registered and inspected pharmacies for the shipping of all prescription weight loss medications. This ensures that the medications you receive, whether they are branded or compounded, adhere to stringent quality and safety standards.
• Branded vs. Compounded Medications: It's important to differentiate. Branded medications like Ozempic®, Zepbound®, and Wegovy® are FDA-approved. Compounded medications, such as Compounded Semaglutide and Compounded Tirzepatide, are prepared by these FDA-registered and inspected pharmacies. While compounded medications are not individually FDA-approved, the pharmacies themselves operate under strict regulatory oversight.
• Medical Supervision: It is crucial to understand that TrimRx partners with these pharmacies for the shipping of weight loss medications and does not provide actual medical supervision. Our platform facilitates access to independent healthcare providers who offer comprehensive medical supervision, including doctor consultations, lab work, and unlimited support, ensuring you receive personalized and safe care throughout your weight loss journey. Our transparent approach means this level of comprehensive service remains consistent, regardless of dosage changes.

Potential Indirect Impacts of Weight Loss Medication While Breastfeeding

Even when a medication does not directly transfer into breast milk in significant amounts, its effect on the mother's body can still indirectly influence the breastfeeding experience. It's essential to consider these broader implications when deciding if Wegovy® or other semaglutide products are right for you while nursing.

Impact on Maternal Nutrition and Milk Supply

Breastfeeding is an energy-intensive process. A nursing mother typically requires an additional 300-500 calories per day to support adequate milk production, depending on her baby's age and feeding frequency. Rapid weight loss, especially if it leads to an aggressive calorie deficit, can potentially impact milk supply.

• Caloric Needs: When taking a GLP-1 agonist like semaglutide, appetite is significantly reduced, which can lead to a substantial drop in caloric intake. If this reduction is too severe or is not carefully managed, it might interfere with the body's ability to produce sufficient breast milk.
• Nutrient Adequacy: Beyond calories, maintaining adequate nutrition is vital for both maternal health and the quality of breast milk. A highly restrictive diet while on weight loss medication could compromise a mother's intake of essential vitamins and minerals, which can impact her energy levels and overall well-being.
• Theoretical Link: While there's no direct research confirming that semaglutide specifically reduces milk supply, the theory exists that rapid weight loss or severe caloric restriction, regardless of the method, could potentially have this effect. Some experts suggest that mothers should aim for a gradual weight loss (e.g., no more than 1-2 pounds per week) while breastfeeding to protect milk supply.

This is precisely where personalized support becomes invaluable. At TrimRx, our comprehensive service includes unlimited support from your care team. They can provide guidance on maintaining adequate nutrition and hydration, strategies for managing appetite while ensuring sufficient caloric intake for lactation, and advice on balancing your weight loss goals with your breastfeeding needs. This personalized attention ensures that your weight loss journey is safe and supportive of your unique circumstances. If you're concerned about balancing your nutrition needs with weight loss goals, our GLP-1 Daily Support and Weight Loss Boost supplements are also available to support overall wellness and nutritional balance.

Monitoring for Infant Adverse Effects

While current studies suggest no adverse effects in breastfed infants exposed to injectable semaglutide, constant vigilance and open communication with healthcare providers are always recommended.

• Individual Variability: Every individual's metabolism and a baby's sensitivity can differ. If a mother begins taking Wegovy® or other semaglutide forms while breastfeeding, it's prudent to monitor the infant for any unusual changes in feeding patterns, weight gain, digestion (e.g., increased fussiness, changes in stool), or general behavior.
• Prompt Reporting: Any observed changes should be promptly reported to the healthcare provider overseeing the mother's weight loss treatment and the pediatrician. This ensures that any potential issues can be addressed quickly and appropriately.

Considerations for Vulnerable Infants

For certain infants, particularly those who are premature, have a low birth weight, or possess underlying medical conditions, caution is advised. These infants may have immature organ systems that could be more sensitive to even minimal drug exposure. In such cases, healthcare providers will likely recommend alternative weight management strategies or advise against using semaglutide until the infant is older and more robust. The decision to use any medication while breastfeeding requires a thorough assessment of these individual factors. To explore personalized options tailored to your specific health profile, we encourage you to take our free assessment quiz.

Navigating the Postpartum Weight Loss Journey with TrimRx

The postpartum weight loss journey can feel overwhelming, but you don't have to navigate it alone. At TrimRx, we are dedicated to providing a supportive, effective, and personalized path to help you achieve your health goals, particularly during significant life stages like breastfeeding.

Our Personalized Approach

Our philosophy is built on the understanding that successful, sustainable weight loss is deeply personal. It requires more than just a generic plan; it demands an approach tailored to your unique physiology, lifestyle, and health objectives.

• Individualized Care: We offer clinically proven, personalized weight loss solutions dedicated to safe, effective weight loss and individualized care. Our platform is a user-friendly and supportive space where individuals receive personalized, medically supervised care—all designed to make sustainable weight loss attainable and tailored to the individual. We believe that sustainable weight loss should be achieved through science, empathy, and a transparent approach.
• Comprehensive Service: When you engage with TrimRx, you gain access to a comprehensive service that includes:
  • Doctor Consultations: Connect with licensed healthcare providers who conduct thorough assessments to determine your eligibility and create a personalized treatment plan. This includes considering your breastfeeding status and any specific concerns you may have.
  • Medication (if eligible): Access to prescription medications like Compounded Semaglutide, Oral Semaglutide, Ozempic®, Compounded Tirzepatide, Oral Tirzepatide, Mounjaro®, Zepbound®, or Wegovy®, sourced from FDA-registered and inspected pharmacies.
  • Lab Work: Necessary lab tests are integrated into your plan to ensure safety and monitor your progress.
  • Unlimited Support: Our care team provides ongoing guidance and answers your questions, offering the empathetic and supportive environment crucial for long-term success.
  • Shipping: Convenient, discreet shipping of your medication directly to your door.
  • No Hidden Fees: We are committed to transparent service, ensuring clarity and consistency throughout your program.

To begin your journey with a plan truly tailored to your needs, we highly encourage you to take our free assessment quiz. This initial step helps us understand your unique situation and determine if our prescription weight loss programs are the right fit for you.

The Role of Doctor Consultation and Ongoing Support

The cornerstone of effective and safe weight management, especially during periods like breastfeeding, is consistent medical supervision. Our programs connect you with independent licensed healthcare providers who are equipped to:

• Assess Eligibility: Carefully evaluate your medical history, current health status, and specific circumstances (including breastfeeding) to determine if a prescription weight loss medication is appropriate and safe for you.
• Develop a Tailored Plan: Create a treatment plan that aligns with your health goals, taking into account the nuanced considerations of postpartum recovery and lactation.
• Provide Ongoing Guidance: Offer continuous professional support, adjusting your treatment plan as needed, monitoring your progress, and addressing any concerns or side effects you may experience. This ongoing care is vital for optimizing results and ensuring your well-being.

Our brand is empathetic, innovative, trustworthy, supportive, results-oriented, and personalized. We offer compassionate care that respects every individual’s unique journey by combining advanced medical science with modern technology. This commitment to continuous, personalized support is what makes TrimRx a trusted partner in your health transformation.

Essential Considerations Beyond Breastfeeding: Wegovy During Pregnancy and Pre-Conception

While our primary focus is on taking Wegovy while breastfeeding, it's equally important for women in their reproductive years to understand the implications of semaglutide use during pregnancy and when planning to conceive. Our commitment to transparent service means providing comprehensive information for all stages of your health journey.

Wegovy and Pregnancy

The consensus among healthcare professionals and regulatory bodies is clear: Wegovy® and other semaglutide products are generally not recommended for use during pregnancy.

• Limited Human Data: There is currently limited data on semaglutide use in human pregnancy. While a few case reports and small studies have not reported an increased chance of birth defects, this data is insufficient to definitively establish safety.
• Animal Studies: Animal studies have shown concerning results. When pregnant animals were given semaglutide, their offspring experienced increased risks of fetal harm, including structural abnormalities, fetal deaths, and changes in growth. While animal studies don't always directly predict human outcomes, they raise significant red flags.
• Weight Loss Not Recommended: Weight loss itself is generally not recommended during pregnancy, as adequate nutritional intake is crucial for fetal development.
• Pregnancy Registry: For individuals who become pregnant while taking Wegovy, a pregnancy registry is available. Such registries collect data on how certain drugs might affect pregnancy, contributing valuable information for future understanding. Your healthcare provider can provide details on how to participate.

Therefore, if you are pregnant or suspect you might be pregnant, it is crucial to contact your healthcare provider immediately. They will almost certainly advise you to stop semaglutide treatment for the duration of your pregnancy.

Planning for Pregnancy While on Wegovy

For women who are taking Wegovy® or other semaglutide medications and are planning a pregnancy, specific precautions are recommended due to the drug's long half-life.

• Discontinuation Period: Experts suggest discontinuing semaglutide at least 2 months (approximately 8 weeks) before attempting to conceive. This recommendation stems from the fact that semaglutide can remain in the body for up to six weeks after the last dose. This washout period is designed to ensure that the drug has sufficiently cleared your system before conception, minimizing potential risks to the developing fetus.
• Birth Control: If you are sexually active and can become pregnant, it's essential to discuss birth control options with your healthcare provider while taking semaglutide and for the recommended two-month period after stopping the medication. This proactive approach helps prevent unintended pregnancies during a time when the drug might still be in your system.
• Pre-Conception Counseling: Engaging in pre-conception counseling with your healthcare provider is highly advisable. They can guide you through the process of safely discontinuing medication, optimizing your health before pregnancy, and discussing the best time to restart weight management treatment after childbirth, considering factors like breastfeeding.

Our commitment at TrimRx is to empower you with knowledge at every stage. We encourage open discussions with the healthcare providers on our platform about your family planning goals so that your weight loss journey can be managed safely and thoughtfully, aligning with your overall life aspirations.

Supporting Your Wellness Journey with TrimRx Quick-Access Supplements

While our personalized prescription programs offer powerful solutions for weight management, we also understand that not everyone is ready for or eligible for prescription medication. Many individuals seek immediate support for their overall wellness, appetite management, or metabolic health. For these needs, TrimRx offers quick-access supplements designed to complement your health journey.

Enhancing Your Health While You Plan

Whether you're exploring eligibility for a prescription program, taking a break from medication, or simply looking for natural ways to support your well-being, our quick-access supplements provide immediate benefits. They are available for direct purchase, without the need for a quiz or doctor consultation, making them easily accessible to support your overall wellness during the weight loss journey.

• GLP-1 Daily Support: This carefully formulated supplement is designed to support the body's natural GLP-1 function. It contains ingredients known to help regulate appetite, support healthy blood sugar levels, and promote metabolic balance. By nurturing these internal processes, GLP-1 Daily Support can be a valuable tool in managing cravings and supporting a feeling of fullness, complementing your dietary efforts.
• Weight Loss Boost: Our Weight Loss Boost supplement is crafted to provide comprehensive support for your metabolism and energy levels. It features ingredients selected to aid in enhancing fat burning, boosting energy, and maintaining focus throughout your day. For those looking for an extra edge in their weight loss efforts or needing a natural pick-me-up, this supplement offers robust support.

These quick-access supplements are a testament to our holistic approach to health. They represent our dedication to providing a range of safe and effective options, ensuring that you have resources to support your wellness journey at every step. You can seamlessly integrate them into your routine to support overall wellness, whether you are currently breastfeeding, planning for pregnancy, or simply focusing on foundational health. They are available for immediate purchase, offering direct support for your ongoing health goals.

Conclusion: Informed Choices for Your Postpartum Health

Navigating weight loss options during the sensitive postpartum period, especially while breastfeeding, presents a unique set of considerations. Our exploration into "can I take Wegovy while breastfeeding" reveals that while injectable semaglutide (like Wegovy® and Ozempic®) shows promising initial data regarding minimal transfer into breast milk and no observed adverse infant effects in limited studies, oral forms (like Rybelsus®) carry greater theoretical concerns due to their unique formulation. Furthermore, the imperative to avoid semaglutide during pregnancy and to plan for a two-month washout period before conception underscores the critical need for careful pre-conception counseling.

Throughout this journey, the unwavering importance of personalized, medically supervised care cannot be overstated. Decisions regarding weight loss medications must always be made in close consultation with a healthcare provider who can assess your individual health profile, consider your baby's well-being, and guide you through the latest research and recommendations.

At TrimRx, we are proud to be your empathetic, innovative, and trustworthy partner in health. Our comprehensive platform is designed to provide you with access to personalized, medically supervised weight loss solutions, including a range of clinically proven medications from FDA-registered and inspected pharmacies. We emphasize transparent service, offering doctor consultations, necessary lab work, unlimited support, and convenient shipping, all without hidden fees. We believe in empowering you with the knowledge and resources to make informed choices, fostering sustainable weight loss through science and compassionate care.

Whether you're ready to explore prescription options like Compounded Semaglutide or Compounded Tirzepatide, or if you're looking for immediate wellness support with our GLP-1 Daily Support and Weight Loss Boost supplements, we are here to support every step of your health transformation. We encourage you to take our free assessment quiz today to see if you qualify for our personalized prescription programs and to embark on a path toward a healthier, more vibrant you. Embrace your postpartum health with confidence, knowing you have a supportive and knowledgeable partner by your side.

Frequently Asked Questions

Can semaglutide affect my breast milk supply?

While current research on injectable semaglutide has not directly shown a negative impact on milk supply, rapid weight loss or significantly reduced caloric intake from any method can theoretically affect lactation. Breastfeeding requires additional calories, so maintaining adequate nutrition is crucial. It's important to discuss your dietary intake and any concerns about milk supply with your healthcare provider and potentially a lactation consultant while on a weight loss program.

How long after stopping Wegovy can I breastfeed?

There isn't a universally established "waiting period" for breastfeeding after stopping Wegovy® (semaglutide), primarily because studies show very low to undetectable levels of injectable semaglutide in breast milk, and no adverse effects in infants have been reported in limited studies. The decision to breastfeed while taking or after stopping Wegovy should be made in consultation with a healthcare provider, weighing the benefits and risks for your specific situation.

What are the potential side effects of Wegovy that could affect my baby?

Based on current limited research, no adverse effects have been reported in healthy, full-term infants whose mothers were taking injectable semaglutide while breastfeeding. However, every baby is different. If you are taking Wegovy® and breastfeeding, monitor your infant for any unusual changes in feeding, growth, digestion (e.g., increased fussiness, changes in stool), or behavior, and report any concerns to your pediatrician and the healthcare provider managing your weight loss plan.

Are there non-prescription options for postpartum weight loss support?

Yes, there are non-prescription options available to support your postpartum weight loss journey. Our quick-access supplements, GLP-1 Daily Support and Weight Loss Boost, are available for immediate purchase to support overall wellness, appetite regulation, and metabolic health. These can be valuable complements to a healthy diet and active lifestyle, whether you're breastfeeding, planning for a prescription program, or seeking general wellness enhancement.